demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 prophylaxis (children)
protein subunit vaccine
Nuvaxovid (NVX-CoV2373) Novavax PREVENT-19 adolescents

0 studies excluded by filtering options 1